Medicines for Europe is marking three decades of delivering equitable access to generic, biosimilar, and value-added medicines at its 30th-anniversary conference in Dublin. Find out more here ⬇ medicinesforireland.ie/mfe-annual-con… #MedsforEU24 #AccessForAll #BreakingBarriers

Yesterday marked an incredible start to the Medicines for Europe 30th Anniversary Annual Conference! As we dive into Day 2, we're energised by the insightful discussions and innovative ideas that set the tone for this pivotal event. #MedsforEU24 #AccessForAll #BreakingBarriers

We would like to thank Colm Burke TD, Minister of State with responsibility for Public Health, Wellbeing and the National Drugs Strategy, for his closing remarks at the Medicines for Europe Annual Conference. #MedsforEU24 #AccessForAll #BreakingBarriers

All patients deserve better and more secure #access to medicines 🫶 Read our latest #PressRelease to discover more on our contribution at the international conference Expert Forum together with other key stakeholders medicinesforeurope.com/wp-content/upl… #AccessForAll

Our Director General, Adrian van den Hoven is speaking at the #EconRoundtableGR on July 2-4 joining other experts for an in-depth analysis of critical global issues, offering valuable insights to decision-makers. Economist Impact events Visit the website for more events.economist.com/events-confere…

💡Access to essential generic & biosimilar medicines is vital for patients. As a new European mandate begins, Medicines for Europe is ready to build a sustainable future based on equity, timely competition and security. #LevellingUp #Access #EUPharmaStrategy #TogetherforHealth

🔄 Off-patent innovation, timely competition and transparent supply chains can drive us towards a future where no patient is left behind.

🙌 We are ready to lead a health revolution with a digital framework that ensures equitable access, harmonisation and sustainability. Read more in our EU manifesto at medicinesforeurope.com/manifesto-2024/

📣 On September 26, join us and Viatris EU Policy at #EHFG2024 for a panel on Access to Europe’s Critical Medicines. We'll explore supply chain resilience and patient access, key to the future #CriticalMedsAct. 📅 September 26, 16:15 – 17:30 👉 Register: rb.gy/pl4vzv

📈 The EU should support off-patent medicine manufacturing, aiming for a competitive, greener future with enhanced strategic autonomy in healthcare. To deliver on this, we are calling for a Critical Medicines Act in the first 100 days of office of the new EU mandate.

🌟 The EU must do more to support affordable innovation by creating a framework for value added and repurposed medicines, which can bring new treatment opportunities to patients.

🔗 Digitalisation in healthcare is more than a trend. We promote a #LevellingUp in healthcare: smarter, more efficient, and more connected than ever.

Today, we spoke at the Greener Pharma Supply Chain workshop by HCWH Europe. Lina Andersson of Viatris EU Policy highlighted our commitment to: 💊 Affordable access to essential medicines ⛓️ Balancing environmental goals with supply reliability 💡 Investing in sustainability

📅 Join us and Viatris EU Policy on September 26, 16:15-17:30, at the GasteinForum. Explore strategies for enhancing supply chain resilience and patient access to critical medicines. 👉 Register: rb.gy/pl4vzv #EHFG2024 #CriticalMeds #SecurityOfSupply

🚀 Embracing open strategic autonomy, competitiveness in Europe will fuel better healthcare for all, #LevellingUp innovation, access, and independence. A Critical Medicines Act should be adopted in the first 100 days of office of the new European Commission.

Do you want to learn more about the future of pharma, sustainable manufacturing and patient access to biosimilars?🌱 📅 From 8-10 October, we await you at #CPHIMilan for dedicated sessions on key topics for the pharma sector. CPHI 👉 Register: ow.ly/Zsug50TiJsh

⏰ The #EHFG2024 is just around the corner! 📅 Join us and Viatris EU Policy on Sept 26, 16:15-17:30, for an interactive panel on #CriticalMeds security. Explore the future of the #CriticalMedsAct with key experts on improving #patient access. 👉 Register: buff.ly/3z0TWSs

📅 It has begun! Today we answer to a very important question for our community: “Why Childhood Cancer should stay high on the EU agenda for 2024-2029?”. CCI Europe 🎗️ The insightful panel discussions and reflections unravel strategies on bridging the gaps between the

💚 #LevellingUp healthcare means not just advanced treatments but also a commitment to sustainability. Europe pioneers a greener future.